Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

1

Influencer promotion of prescription drugs raises public health concerns due to misinformation and limited regulatory oversight.
2

Many influencers present health information beyond their expertise, often overstating benefits and omitting alternative treatments.
3

Regulatory gaps exist, with vague FDA and FTC guidance making enforcement of disclosure rules challenging for influencer content.
4

Parasocial relationships with influencers can reduce audience recognition of persuasive intent, leading to more favorable attitudes toward promoted drugs.
5

Researchers advocate for clearer regulations, standardized disclosures, and improved digital health literacy to mitigate risks associated with influencer promotions.

1